Autoimmune disease and gender: Plausible mechanisms for the female predominance of autoimmunity

Journal of Autoimmunity

Volumn 38, Issue 2-3, 2012, Pages

  Quintero, Olga L ^a   Amador Patarroyo, Manuel J ^a   Montoya Ortiz, Gladys ^a   Rojas Villarraga, Adriana ^a   Anaya, Juan Manuel ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Autoimmune diseases; Gender differences; Sex hormones; X chromosome

Indexed keywords

ANDROGEN; BROMOCRIPTINE; ESTROGEN; ESTROGEN RECEPTOR; PROLACTIN;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE ACTIVATION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; GENETIC RISK; HORMONAL REGULATION; HUMAN; HUMORAL IMMUNITY; KLINEFELTER SYNDROME; LYMPHOMA; MICROCHIMERISM; MONOCYTE; MONOSOMY X; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NEUTROPHIL; ONSET AGE; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RAYNAUD PHENOMENON; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; X CHROMOSOME; X CHROMOSOME INACTIVATION; Y CHROMOSOME;

AUTOIMMUNE DISEASES; AUTOIMMUNITY; CHIMERISM; CHROMOSOMES, HUMAN, X; FEMALE; HORMONES; HUMANS; MALE; PREGNANCY; SEX FACTORS;

EID: 84858752604     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.10.003     Document Type: Article

References (131)

1. Fairweather D.L., Frisancho-Kiss S., Rose N.R. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008, 173:600-609.
2. Oliver J.E., Silman A.J. Why are women predisposed to autoimmune rheumatic diseases?. Arthritis Res Ther 2009, 11:252-260.
3. Jacobson D.L., Gange S.J., Rose N.R., Graham N.M. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 1997, 84:223-243.
4. Whitacre C.C. Sex differences in autoimmune disease. Nat Immunol 2001, 2:777-780.
5. Kivity S., Ehrenfeld M. Can we explain the higher prevalence of autoimmune disease in women?. Expert Rev Clin Immunol 2010, 6:691-694.
6. Sellner J., Kraus J., Awad A., Milo R., Hemmer B., Stüve O. The increasing incidence and prevalence of female multiple sclerosis-a critical analysis of potential environmental factors. Autoimmun Rev 2011, 10:495-502.
7. Borchers A.T., Naguwa S.M., Shoenfeld Y., Gershwin M.E. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010, 9:A277-A287.
8. Rojas-Villarraga A., Toro C.E., Espinosa G., Rodríguez-Velosa Y., Duarte-Rey C., Mantilla R.D., et al. Factors influencing polyautoimmunity in systemic lupus erythematosus. Autoimmun Rev 2010, 9:229-232.
9. Amadori A., Zamarchi R., De Silvestro G., Forza G., Cavatton G., Danieli G.A., et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med 1995, 1:1279-1283.
10. Shames R.S. Gender differences in the development and function of the immune system. J Adolesc Health 2002, 30:59-70.
11. Cutolo M., Capellino S., Sulli A., Serioli B., Secchi M.E., Villaggio B., et al. Estrogens and autoimmune diseases. Ann N Y Acad Sci 2006, 1089:538-547.
12. Lleo A., Battezzati P.M., Selmi C., Gershwin M.E., Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630.
13. McCarthy M. The' gender gap' in autoimmune disease. Lancet 2000, 356:1088.
14. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 2007, 28:1-6.
15. Beagley K.W., Gockel C.M. Regulation of innate and adaptive immunity by the female sex hormones oestradiol and progesterone. FEMS Immunol Med Microbiol 2003, 38:13-22.
16. McMurray R.W. Estrogen, prolactin, and autoimmunity: actions and interactions. Int Immunopharmacol 2001, 1:995-1008.
17. Raveche E.S., Steinberg A.D., Berczi I. Sex hormones in autoimmunity. Pituitary Funct Immun 1986, 283-301.
18. Rubtsov A.V., Rubtsova K., Kappler J.W., Marrack P. Genetic and hormonal factors in female-biased autoimmunity. Autoimmun Rev 2010, 9:494-498.
19. Jansson L., Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm Res 1998, 47:290-301.
20. Prabhala R.H., Wira C.R. Sex hormone and IL-6 regulation of antigen presentation in the female reproductive tract mucosal tissues. J Immunol 1995, 155:5566-5573.
21. Peeva E., Zouali M. Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes. Immunol Lett 2005, 101:123-143.
22. Zandman-Goddard G., Peeva E., Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372.
23. Yacoub Wasef S.Z. Gender differences in systemic lupus erythematosus. Gend Med 2004, 1:12-17.
24. Roubinian J.R., Talal N., Greenspan J.S., Goodman J.R., Siiteri P.K. Effect of castration and sex hormone treatment on survival, anti-nucleic acid antibodies, and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1978, 147:1568-1583.
25. Orbach H., Zandman-Goddard G., Amital H., Barak V., Szekanecz Z., Szucs G., et al. Novel biomarkers in autoimmune diseases. Ann N Y Acad Sci 2007, 1109:385-400.
26. Gutierrez M.A., Molina J.F., Jara L.J., Cuellar M.L., Garcia C., Gutierrez-Ureña S., et al. Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity. Lupus 1995, 4:348-352.
27. Chan R.W., Tam L.S., Li E.K., Lai F.M., Chow K.M., Lai K.B., et al. Inflammatory cytokine gene expression in the urinary sediment of patients with lupus nephritis. Arthritis Rheum 2003, 48:1326-1331.
28. Walker S.E. Bromocriptine treatment of systemic lupus erythematosus. Lupus 2001, 10:762-768.
29. Lahita R.G., Bradlow H.L., Ginzler E., Pang S., New M. Low plasma androgens in women with systemic lupus erythematosus. Arthritis Rheum 1987, 30:241-248.
30. Sequeira J.F., Keser G., Greenstein B., Wheeler M.J., Duarte P.C., Khamashta M.A., et al. Systemic lupus erythematosus: sex hormones in male patients. Lupus 1993, 2:315-317.
31. Verheul H.A., Verveld M., Hoefakker S., Schuurs A.H. Effects of ethinylestradiol on the course of spontaneous autoimmune disease in NZB/W and NOD mice. Immunopharmacol Immunotoxicol 1995, 17:163-180.
32. Mavragani C.P., Moutsopoulos H.M. The geoepidemiology of Sjögren's syndrome. Autoimmun Rev 2010, 9:A305-A310.
33. Anaya J.M., McGuff H.S., Banks P.M., Talal N. Clinicopathological factors relating malignant lymphoma with Sjogren's syndrome. Semin Arthritis Rheum 1996, 25:337-346.
34. Baimpa E., Dahabreh I.J., Voulgarelis M., Moutsopoulos H.M. Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 2009, 88:284-293.
35. Molina R., Provost T.T., Arnett F.C., Bias W.B., Hochberg M.C., Wilson R.W., et al. Primary Sjögren's syndrome in men:: clinical, serologic, and immunogenetic features. Am J Med 1986, 80:23-31.
36. Anaya J.M., Liu G.T., D'Souza E., Ogawa N., Luan X., Talal N. Primary Sjögren's syndrome in men. Ann Rheum Dis 1995, 54:748-751.
37. Drosos A.A., Tsiakou E.K., Tsifetaki N., Politi E.N., Siamopoulou-Mavridou A. Subgroups of primary Sjögren's syndrome. Sjögren's syndrome in male and paediatric Greek patients. Ann Rheum Dis 1997, 56:333-335.
38. Cervera R., Font J., Ramos-Casals M., Garcia-Carrasco M., Rosas J., Morla R.M., et al. Primary Sjogren's syndrome in men: clinical and immunological characteristics. Lupus 2000, 9:61-64.
39. Horvath I.F., Szodoray P., Zeher M. Primary Sjögren's syndrome in men: clinical and immunological characteristic based on a large cohort of Hungarian patients. Clin Rheumatol 2008, 27:1479-1483.
40. Gondran G., Fauchais A., Lambert M., Ly K., Launay D., Queyrel V., et al. Primary Sjögren's syndrome in men. Scand J Rheumatol 2008, 37:300-305.
41. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13:635-638.
42. Castagnetta L.A., Carruba G., Granata O.M., Stefano R., Miele M., Schmidt M., et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003, 30:2597-2605.
43. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Pizzorni C., et al. Anti TNF and sex hormones. Ann N Y Acad Sci 2006, 1069:391-400.
44. Jacobsson L.T., Turesson C., Nilsson Jå, Petersson I.F., Lindqvist E., Saxne T., et al. Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis. Ann Rheum Dis 2007, 66:670-675.
45. Zoli A., Lizzio M.M., Ferlisi E.M., Massafra V., Mirone L., Barini A., et al. ACTH, cortisol and prolactin in active rheumatoid arthritis. Clin Rheumatol 2002, 21:289-293.
46. Tobón G.J., Youinou P., Saraux A. The environment, geo-epidemiology, and autoimmune disease: rheumatoid arthritis. Autoimmun Rev 2010, 9:A288-A292.
47. Spector T.D., Perry L.A., Tubb G., Silman A.J., Huskisson E.C. Low free testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988, 47:65-68.
48. Cutolo M., Seriolo B., Villaggio B., Pizzorni C., Craviotto C., Sulli A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci 2002, 966:131-142.
49. Chifflot H., Fautrel B., Sordet C., Chatelus E., Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008, 37:223-235.
50. LeRoy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205.
51. Shi-Wen X., Panesar M., Vancheeswaran R., Mason J., Haskard D., Black C., et al. Expression and shedding of intercellular adhesion molecule 1 and lymphocyte function-associated antigen 3 by normal and scleroderma fibroblasts. Effects of interferon-gamma, tumor necrosis alpha and estrogen. Arthritis Rheum 1994, 37:1689-1697.
52. Straub R.H., Zeuner M., Lock G., Schölmerich J., Lang B. High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis. Br J Rheumatol 1997, 36:426-432.
53. Nicot A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci 2009, 14:4477-4515.
54. Azar S.T., Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocr Res 1999, 25:207-214.
55. Tomassini V., Onesti E., Mainero C., Giugni E., Paolillo A., Salvetti M., et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatr 2005, 76:272-275.
56. Zandman-Goddard G., Peeva E., Rozman Z., Ben-Zvi I., Langevitz P., Shvartser Y., et al. Sex and gender differences in autoimmune diseases. Sex and gender aspects in clinical medicine 2012, 101-124. Springer-Verlag London Limited, New York. S. Oertelt-Prigione, V. Regitz-Zagrosek (Eds.).
57. Ishimaru N., Arakaki R., Watanabe M., Kobayashi M., Miyazaki K., Hayashi Y. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in estrogen-deficient mice of healthy background. Am J Pathol 2003, 163:1481-1490.
58. Shim G.J., Warner M., Kim H.J., Andersson S., Liu L., Ekman J., et al. Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome. Proc Natl Acad Sci U S A 2004, 101:12628-12633.
59. Laroche M., Borg S., Lassoued S., De Lafontan B., Roché H. Joint pain with aromatase inhibitors: abnormal frequency of Sjögren's syndrome. J Rheumatol 2007, 34(11):2259-2263.
60. El Miedany Y.M., Ahmed I., Moustafa H., El Baddini M. Hyperprolactinemia in Sjogren's syndrome: a patient subset or a disease manifestation?. Joint Bone Spine 2004, 71(3):203-208.
61. Haga H.J., Rygh T. The prevalence of hyperprolactinemia in patients with primary Sjögren's syndrome. J Rheumatol 1999, 26(6):1291-1295.
62. Ostensen M., Aune B., Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand J Rheumatol 1983, 12:69-72.
63. Clowse M.E. Lupus activity in pregnancy. Rheum Dis Clin North Am 2007, 33:237-252.
64. Andreoli L., Bazzani C., Taraborelli M., Reggia R., Lojacono A., Brucato A., et al. Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. Autoimmun Rev 2010, 10:51-54.
65. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today 1993, 14:353-356.
66. Marzi M., Vigano A., Trabattoni D., Salvaggio A., Clerici E., Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996, 106:127-133.
67. Gusdon J.P. Fetal and maternal immunoglobulin levels during pregnancy. Am J Obstet Gynecol 1969, 103:895-900.
68. Gladman D.D., Tandon A., Ibañez D., Urowitz M.B. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 2010, 37:754-758.
69. Imbasciati E., Tincani A., Gregorini G., Doria A., Moroni G., Cabiddu G., et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2009, 24:519-525.
70. Olsen N.J., Kovacs W.J. Hormones, pregnancy, and rheumatoid arthritis. J Gend Specif Med 2002, 5:28-37.
71. Hazes J.M., Coulie P.G., Geenen V., Vermeire S., Carbonnel F., Louis E., et al. Rheumatoid arthritis and pregnancy: evolution of disease activity and pathophysiological considerations for drug use. Rheumatology (Oxford) 2011, [Epub ahead of print].
72. Buyon J.P. Neonatal lupus. Curr Opin Rheumatol 1996, 8:485-490.
73. Costenbader K.H., Feskanich D., Stampfer M.J., Karlson E.W. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007, 56:1251-1262.
74. Karlson E.W., Mandl L.A., Hankinson S.E., Grodstein F. Do breast feeding and other reproductive factors influence future risk of rheumatoid arthritis?: Results from the Nurses' health study. Arthritis Rheum 2004, 50:3458-3467.
75. Zorgdrager A., De Keyser J. Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci 1997, 149:95-97.
76. Whitacre C.C., Reingold S.C., O'Looney P.A., Blankenhorn E., Brinley F., Collier E., et al. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
77. Goemaere S., Ackerman C., Goethals K., De Keyser F., Van der Straeten C., Verbruggen G., et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 1990, 17:1620-1622.
78. Lahita R.G. Sex steroids and the rheumatic diseases. Arthritis Rheum 1985, 28:121-126.
79. Arnason B.G., Richman D.P. Effect of oral contraceptives on experimental demyelinating disease. Arch Neurol 1969, 21:103-108.
80. Liang M.H., Karlson E.W. Female hormone therapy and the risk of developing or exacerbating systemic lupus erythematosus or rheumatoid arthritis. Proc Assoc Am Physicians 1996, 108:25-28.
81. Petri M. Sex hormones and systemic lupus erythematosus. Lupus 2008, 17:412-415.
82. Lockshin M.D. Sex differences in autoimmune disease. Lupus 2006, 15:753-756.
83. Nalbandian G., Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005, 31:91-106.
84. Greer J.M., McCombe P.A. Role of gender in multiple sclerosis: clinical effects and potential molecular mechanisms. J Neuroimmunol 2011, 234:7-18.
85. Aggarwal R., Namjou B., Li S., D'Souza A., Tsao B.P., Bruner B.F., et al. Male-only systemic lupus. J Rheumatol 2010, 37:1480-1487.
86. Lyon M.F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961, 190:372-373.
87. Brown C.J. Skewed X-chromosome inactivation: cause or consequence?. J Natl Cancer Inst 1999, 91:304-305.
88. Sharp A., Robinson D., Jacobs P. Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 2000, 107:343-349.
89. Chitnis S., Monteiro J., Glass D., Apatoff B., Salmon J., Concannon P., et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res 2000, 2:399-406.
90. Uz E., Loubiere L.S., Gadi V.K., Ozbalkan Z., Stewart J., Nelson J.L., et al. Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 2008, 34:352-355.
91. Uz E., Mustafa C., Topaloglu R., Bilginer Y., Dursun A., Kasapcopur O., et al. Increased frequency of extremely skewed X chromosome inactivation in juvenile idiopathic arthritis. Arthritis Rheum 2009, 60:3410-3412.
92. Ozbalkan Z., Bagişlar S., Kiraz S., Akyerli C.B., Ozer H.T., Yavuz S., et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570.
93. Ozcelik T., Uz E., Akyerli C.B., Bagislar S., Mustafa C.A., Gursoy A., et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur J Hum Genet 2006, 14:791-797.
94. Brix T.H., Knudsen G.P., Kristiansen M., Kyvik K.O., Orstavik K.H., Hegedus L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J Clin Endocrinol Metab 2005, 90:5949-5953.
95. Knudsen G.P., Harbo H.F., Smestad C., Celius E.G., Akesson E., Oturai A., et al. X chromosome inactivation in females with multiple sclerosis. Eur J Neurol 2007, 14:1392-1396.
96. Miozzo M., Selmi C., Gentilin B., Grati F.R., Sirchia S., Oertelt S., et al. Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis. Hepatology 2007, 46:456-462.
97. Yin X., Latif R., Tomer Y., Davies T.F. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann N Y Acad Sci 2007, 1110:193-200.
98. Chabchoub G., Uz E., Maalej A., Mustafa C.A., Rebai A., Mnif M., et al. Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis Res Ther 2009, 11:R106-R113.
99. Knudsen G.P. Gender bias in autoimmune diseases: X chromosome inactivation in women with multiple sclerosis. J Neurol Sci 2009, 286:43-46.
100. Invernizzi P., Miozzo M., Selmi C., Persani L., Battezzati P.M., Zuin M., et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
101. Invernizzi P. The X chromosome in female-predominant autoimmune diseases. Ann N Y Acad Sci 2007, 1110:57-64.
102. Invernizzi P., Pasini S., Selmi C., Gershwin M.E., Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009, 33:12-16.
103. Invernizzi P., Miozzo M., Battezzati P.M., Bianchi I., Grati F.R., Simoni G., et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 2004, 363:533-535.
104. Invernizzi P., Miozzo M., Oertelt-Prigione S., Meroni P.L., Persani L., Selmi C., et al. X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1110:84-91.
105. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol 2008, 22:913-922.
106. Ortiz-Neu C., LeRoy E.C. The coincidence of Klinefelter's syndrome and systemic lupus erythematosus. Arthritis Rheum 1969, 12:241-246.
107. Gilliland W.R., Stashower M.E. Klinefelter's syndrome and systemic lupus erythematosus. Clin Exp Rheumatol 2000, 18:107-109.
108. Smith-Bouvier D.L., Divekar A.A., Sasidhar M., Du S., Tiwari-Woodruff S.K., King J.K., et al. A role for sex chromosome complement in the female bias in autoimmune disease. J Exp Med 2008, 205:1099-1108.
109. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008, 58:2511-2517.
110. ten Wolde S., Breedveld F.C., de Vries R.R., D'Amaro J., Rubenstein P., Schreuder G.M., et al. Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet 1993, 341:200-202.
111. Barrera P., Balsa A., Alves H., Westhovens R., Maenaut K., Cornelis F., et al. Noninherited maternal antigens do not increase the susceptibility for familial rheumatoid arthritis. European Consortium on rheumatoid arthritis families (ECRAF). J Rheumatol 2001, 28:968-974.
112. Bronson P.G., Komorowski L.K., Ramsay P.P., May S.L., Noble J., Lane J.A., et al. Analysis of maternal-offspring HLA compatibility, parent-of-origin effects, and noninherited maternal antigen effects for HLA-DRB1 in systemic lupus erythematosus. Arthritis Rheum 2010, 62:1712-1717.
113. Barrera P., Balsa A., Alves H., Westhovens R., Maenaut K., Cornelis F., et al. Noninherited maternal antigens do not play a role in rheumatoid arthritis susceptibility in Europe. European Consortium on rheumatoid arthritis families. Arthritis Rheum 2000, 43:758-764.
114. Harney S., Newton J., Milicic A., Brown M.A., Wordsworth B.P. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 2003, 42:171-174.
115. van der Horst-Bruinsma I.E., Hazes J.M., Schreuder G.M., Radstake T.R., Barrera P., van de Putte L.B., et al. Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis. Ann Rheum Dis 1998, 57:672-675.
116. Feitsma A.L., Worthington J., van der Helm-van Mil A.H., Plant D., Thomson W., Ursum J., et al. Protective effect of noninherited maternal HLA-DR antigens on rheumatoid arthritis development. Proc Natl Acad Sci U S A 2007, 104:19966-19970.
117. Akesson K., Carlsson A., Ivarsson S.A., Johansson C., Weidby B.M., Ludvigsson J., et al. The non-inherited maternal HLA haplotype affects the risk for type 1 diabetes. Int J Immunogenet 2009, 36:1-8.
118. Guthrie K.A., Tishkevich N.R., Nelson J.L. Non-inherited maternal human leukocyte antigen alleles in susceptibility to familial rheumatoid arthritis. Ann Rheum Dis 2009, 68:107-109.
119. Bianchi D.W., Zickwolf G.K., Weil G.J., Sylvester S., DeMaria M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996, 93:705-708.
120. Evans P.C., Lambert N., Maloney S., Furst D.E., Moore J.M., Nelson J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
121. Willer C.J., Sadovnick A.D., Ebers G.C. Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis. J Neuroimmunol 2002, 126:126-133.
122. Lockshin M.D. Invited review: sex ratio and rheumatic disease. J Appl Physiol 2001, 91:2366-2373.
123. Ranque B., Mouthon L. Geoepidemiology of systemic sclerosis. Autoimmun Rev 2010, 9:A311-A318.
124. Artlett C.M., Smith J.B., Jimenez S.A. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998, 338:1186-1191.
125. Nelson J.L., Furst D.E., Maloney S., Gooley T., Evans P.C., Smith A., et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559-562.
126. Willer C.J., Herrera B.M., Morrison K.M., Sadovnick A.D., Ebers G.C. Association between microchimerism and multiple sclerosis in Canadian twins. J Neuroimmunol 2006, 179:145-151.
127. Klintschar M., Schwaiger P., Mannweiler S., Regauer S., Kleiber M. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 2001, 86:2494-2498.
128. Mosca M., Curcio M., Lapi S., Valentini G., D'Angelo S., Rizzo G., et al. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis 2003, 62:651-654.
129. Lambert N.C., Pang J.M., Yan Z., Erickson T.D., Stevens A.M., Furst D.E., et al. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005, 64:845-848.
130. Rak J.M., Maestroni L., Balandraud N., Guis S., Boudinet H., Guzian M.C., et al. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009, 60:73-80.
131. Walsh S.J., Rau L.M. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United states. Am J Public Health 2000, 90:1463-1466.